Exact claim · Version 1 · Reviewed 2026-07-23
“Teduglutide is a general gut-healing peptide.”
A verdict on this wording and scope, not a universal grade for Teduglutide.
01 · Verdict
Misleading
The approved indication and outcome are specific to short bowel syndrome with parenteral-support dependence.
- Evidence basis
- Regulatory or product record
- Scope
- The current Gattex indication.
- Category
- Clinical outcomes
02 · Primary record
Check the attached evidence
- Editorial review
- Internal editorial review recorded
- Responsible editor
- Anthony Treviso · Founder and responsible editor
- Clinical-review boundary
- Not independently medically reviewed.